Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia
京都大学 === 0048 === 新制・課程博士 === 博士(医学) === 甲第19363号 === 医博第4040号 === 新制||医||1011(附属図書館) === 32377 === 新制||医||1011 === 京都大学大学院医学研究科医学専攻 === (主査)教授 小柳 義夫, 教授 河本 宏, 教授 松岡 雅雄 === 学位規則第4条第1項該当 === Doctor of Medical Science === Kyoto University === DFAM...
Main Author: | Tada, Kohei |
---|---|
Other Authors: | 小柳, 義夫 |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Kyoto University
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/2433/202797 |
Similar Items
-
Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy
by: Langdahl Bente L, et al.
Published: (2011-10-01) -
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia
by: Takiuchi, Yoko
Published: (2018) -
Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Sharlene Ho, et al.
Published: (2020-05-01) -
Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011-06-01) -
The Effect of Abacavir on Inflammation and Endothelial Cell Activation in Adults with HIV Infection
by: Hileman, Corrilynn O.
Published: (2010)